Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Switch collaborative study
2011-002107-15Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of aprepitant in Human immunodeficiency virus infection type 1 and human immunodeficiency virus infection (HIV) (3 arms), sponsored by The Kirby Institute. Started Sep 2011; status: completed.
02
Drugs
aprepitant
03
Conditions
Human immunodeficiency virus infection type 1human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-002107-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002107-15.